猪繁殖与呼吸综合征病毒变异株ORF6基因的克隆与原核表达研究

根据GenBank中美洲型猪繁殖与呼吸综合征病毒(PRRSV)的ORF6基因序列,设计合成一对特异性引物,应用RT-PCR方法扩增出PRRSV的ORF6基因(M基因)。将所扩增片段克隆入原核表达载体pET-32a(+),pET-ORF6重组质粒转化DH5a宿主菌后,经双酶切、PCR鉴定后挑选阳性克隆测序鉴定并对插入的ORF6基因序列进行分析。结果表明,ORF6基因的原核表达载体构建成功。ORF6基因推导的氨基酸与美洲型相应基因的同源性为96.0%～100%,与LV株的同源性为79.9%,系统进化树表明该PRRSV属于美洲型。将构建成功的重组质粒pET-ORF6转化BL21,诱导后经SDS-PAGE和Western-blot分析表明:克隆在HIS标签的膜基质蛋白基因与HIS获得了高效表达,表达的融合蛋白HIS-M分子量约为39kDa,并且有免疫学反应活性。     

鸡的人工授精与自然交配种蛋孵化对比试验

该试验选用鸡的人工授精种蛋９４０枚及自然交配种蛋９６０枚,做了鸡的人工授精与自然资本种蛋孵化试验,结果表明：鸡人工授精后６ｄ内种蛋受精率平均为９４．５％,７ｄ后,受经极显著降低;人工授精后的种蛋受经及入孵种蛋孵化率均极显著高于自然交配组,两两者的受精种蛋孵化率无明显差异;另外,在试验过程中,还研究了种蛋贮存时间与化结果的关系,发现种蛋贮存期越短,孵化效果越好,贮存期最长不应超过７ｄ。     

Molecular cloning and expression analysis of porcine gamma-interferon-inducible lysosomal thiol reductase (GILT)

A porcine interferon-gamma-inducible lysosomal thiol reductase (GILT) cDNA, designated pGILT, was cloned by RT-PCR and rapid amplification of cDNA ends (RACE) strategies. The full-length cDNA of pGILT consists of 1,062 bp with a 741 bp open reading frame, encoding 246 amino acids, with a putative molecular weight of 29.5 kDa. The deduced pGILT possesses the typical structural feature of mammalian GILT, including an active-site CXXC motif, a GILT signature sequence CQHGX(2)ECX(2)NX(4)C, and 10 conserved cysteines. The genomic DNA sequence of pGILT contains seven exons and six introns, which is similar to vertebrate GILT exon-intron organization. The result of real-time PCR showed that GILT is expressed in many tissues in the pig, including spleen, liver, lung, heart, intestine, blood and kidney. And the pGILT expression is obviously up-regulated in spleen and blood after induction with LPS. These results suggesting that pGILT is highly likely to play a role in the innate immune responses in porcine. It also provided the basis for investigations on the role of GILT in this important domestic species and an animal model for human diseases.     

猪生殖--呼吸道综合征(PRRS)的诊断与防制

1987年在美国北卡罗来纳州、明尼苏达州以及衣阿华州等地的猪群中爆发了一系列令人震惊的"流产风暴",特征是妊娠母猪发生晚期流产、早产、死胎和木乃伊胎,以及仔猪出现呼吸道病和高死亡率.由于该病前所未闻且病原不明,故被称为"猪神秘病"(MSD)[1-4].其后,加拿大报道了类似的病症[5].1990年冬,欧洲开始流行MSD,首先在德国出现[6].继而,在荷兰、西班牙、比利时、英国、法国等养猪业较发达的欧洲国家陆续爆发了本病[7-10].     

蛋鸡种蛋蛋重对孵化率和雏鸡生长发育的影响

将豫州褐壳蛋的种蛋按重量大小分成6组，在相同的条件下进行孵化和饲养试验。结果表明，蛋重在53－56克的种蛋，其受精蛋孵化率最高；不同的蛋重对雏鸡的初生重以及雏鸡在1－3周龄的体重影响较大，蛋重与初生重（γ=0．9899）、1周龄体重（γ＝0．9528）的相关极显著；蛋重与2周龄体重（γ＝0．9032）、3周龄体重（γ＝0．9040）相关显著，与3周龄以后雏鸡体重相关不显著。     

猪弓形虫实时荧光PCR检测方法的建立与应用

为建立一种快速、敏感、特异的猪弓形虫检测方法,根据弓形虫保守基因序列,设计一套特异性引物和FAM荧光素标记的MGB探针;通过对PCR反应体系和反应条件进行优化筛选,建立了猪弓形虫实时荧光定量PCR检测方法,并对此PCR检测方法进行了特异性、敏感性、重复性试验;利用所建立的方法对60份疑似弓形虫感染的临床样品进行了检测。结果显示:建立的猪弓形虫实时荧光定量PCR检测方法在101～107拷贝/μL模板范围内有很好的线性关系;对弓形虫重组阳性质粒出现阳性扩增信号,但对阴性对照的水和其他7种病原对照未扩增出特异性曲线;最低检测模板浓度为10拷贝/μL;自60份疑似猪弓形虫感染样品中检出32份阳性,并且和克隆测序结果一致。结果表明,本研究建立的猪弓形虫实时荧光定量PCR检测方法可用于猪弓形虫的快速检测,从而为猪弓形虫病的诊断提供了特异、敏感、高通量的方法。     

一起饲料未落实留样观察制度案的查处

2019年7月,A市农业综合执法支队执法人员在执法检查中发现,×宠物饲料有限公司涉嫌未落实留样观察制度而从事饲料生产。经立案调查,认定当事人违法事实存在,证据确凿。根据《饲料和饲料添加剂管理条例》规定,依法给予了行政处罚。本文重点介绍了案件的发生、查处经过、法律适用及处理情况等执法内容,讨论了饲料留样目的和意义、调查取证注意事项、违法物品的处理以及责令改正的正确适用等问题,指出了办理此类案件时的取证依据、处罚前置条件,以期为行政执法人员办理同类案件提供参考。     

Immunoadjuvant effects of hemagglutinating virus of Japan envelope (HVJ-E) on the inactivated H9 subtype avian influenza virus vaccine

Avian influenza viruses (AIV) of the H9 subtype cause serious health problems in chickens, resulting in great economic losses to the poultry industry worldwide. The killed vaccine (KV) against H9 subtype AIV has been widely used in China since 1998 but has been linked with side effects in chickens and only partial protection. A few studies have demonstrated the immunostimulatory effects of the hemagglutinating virus of Japan envelope (HVJ-E) in cancer therapy. In this study, the adjuvant efficacy and the protective effects of HVJ-E, in combination with H9N2 AI KV against AIV were evaluated. The maturation of murine dendritic cells treated by HVJ-E was verified by FACS in the current experiment, then the antibody hemagglutination inhibition (HI) titers and cytokines and the post-challenge virological profiles (oropharyngeal and cloacal virus shedding) were investigated to define the immune responses in chickens. Our findings indicate that HVJ-E could induce dendritic cell (DC) maturation in mice. Injection of HVJ-E in chickens resulted in raised levels of IFN-β and IFN-γ being present in sera suggesting a stimulatory effect in these animals. The antibody responses to AIV of chickens inoculated with HVJ-E adjuvanted killed H9-AIV were higher than those of chickens inoculated with oil adjuvanted H9-HIV. Furthermore, although inoculation of either HVJ-E or oil adjuvanted AIV reduced virus shedding following challenge, compared to controls, HVJ-E adjuvanted AIV was more effective in reducing shedding than oil adjuvant.     

Protective immune responses induced by in ovo immunization with recombinant adenoviruses expressing spike (S1) glycoprotein of infectious bronchitis virus fused/co-administered with granulocyte-macrophage colony stimulating factor

Infectious bronchitis virus (IBV) causes tremendous economic losses associated with production inefficiencies and mortality in poultry industry worldwide. In the present report, the recombinant adenoviruses expressing chicken granulocyte-macrophage colony stimulating factor (GM-CSF) and S1 gene of nephropathogenic IBV were constructed and characterized. Then, the immunological efficacy and protection against homologous IBV challenge were assessed in specific pathogen free (SPF) chickens. The results showed that the chickens vaccinated in ovo with rAd-S1, rAd-GM-S1 (GM-CSF fused with S1 using glycine linkers) and rAd-GM-CSF plus rAd-S1 (co-administered) developed specific anti-IBV HI antibodies. Moreover, the fusion of the GM-CSF markedly increased spleen cell proliferation and IFN-γ production while mild increased in IL-4 production, which demonstrated the enhancement of cell-mediated immune responses. Following challenge with IBV, the chickens in the group vaccinated with rAd-S1 fused or co-administered with GM-CSF had fewer nephropathic lesions and showed 100% protection as compared to that of rAd-S1 alone which showed 70% protection. It indicated that the single dose in ovo vaccination of the GM-CSF fused or co-administered with S1 of IBV could enhance significantly the humoral, cellular immune responses and provide complete protection against nephropathogenic IBV challenge. This finding may provide basic information for effective in ovo vaccines design against IBV.